506 related articles for article (PubMed ID: 33042264)
21. Hepatitis C virus infection suppresses hepatitis B virus replication via the RIG-I-like helicase pathway.
Murai K; Hikita H; Kai Y; Kondo Y; Fukuoka M; Fukutomi K; Doi A; Yamai T; Nakabori T; Fukuda R; Takahashi T; Miyakawa K; Suemizu H; Ryo A; Yamada R; Kodama T; Sakamori R; Tatsumi T; Takehara T
Sci Rep; 2020 Jan; 10(1):941. PubMed ID: 31969598
[TBL] [Abstract][Full Text] [Related]
22. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA HULC activates HBV by modulating HBx/STAT3/miR-539/APOBEC3B signaling in HBV-related hepatocellular carcinoma.
Liu Y; Feng J; Sun M; Yang G; Yuan H; Wang Y; Bu Y; Zhao M; Zhang S; Zhang X
Cancer Lett; 2019 Jul; 454():158-170. PubMed ID: 30981758
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N
Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of MicroRNA-145 Caused by Hepatitis B Virus X Protein Promotes Expression of CUL5 and Contributes to Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Gao F; Sun X; Wang L; Tang S; Yan C
Cell Physiol Biochem; 2015; 37(4):1547-59. PubMed ID: 26512974
[TBL] [Abstract][Full Text] [Related]
26. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
Cao F; Yin LX
Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
[TBL] [Abstract][Full Text] [Related]
27. EpCAM-regulated intramembrane proteolysis induces a cancer stem cell-like gene signature in hepatitis B virus-infected hepatocytes.
Mani SK; Zhang H; Diab A; Pascuzzi PE; Lefrançois L; Fares N; Bancel B; Merle P; Andrisani O
J Hepatol; 2016 Nov; 65(5):888-898. PubMed ID: 27238755
[TBL] [Abstract][Full Text] [Related]
28. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
[TBL] [Abstract][Full Text] [Related]
29. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
30. UBE2L3, a susceptibility gene that plays oncogenic role in hepatitis B-related hepatocellular carcinoma.
Liu Y; Song C; Ni H; Jiao W; Gan W; Dong X; Liu J; Zhu L; Zhai X; Hu Z; Li J
J Viral Hepat; 2018 Nov; 25(11):1363-1371. PubMed ID: 29969176
[TBL] [Abstract][Full Text] [Related]
31. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
[TBL] [Abstract][Full Text] [Related]
32. Intrahepatic hepatitis B virus large surface antigen induces hepatocyte hyperploidy via failure of cytokinesis.
Li TN; Wu YJ; Tsai HW; Sun CP; Wu YH; Wu HL; Pei YN; Lu KY; Yen TT; Chang CW; Chan HL; Tao MH; Liou JY; Chang MD; Su IJ; Wang LH
J Pathol; 2018 Aug; 245(4):502-513. PubMed ID: 29862509
[TBL] [Abstract][Full Text] [Related]
33. Increased ERp57 Expression in HBV-Related Hepatocellular Carcinoma: Possible Correlation and Prognosis.
Liu M; Du L; He Z; Yan L; Shi Y; Shang J; Tang H
Biomed Res Int; 2017; 2017():1252647. PubMed ID: 28373975
[No Abstract] [Full Text] [Related]
34. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
[TBL] [Abstract][Full Text] [Related]
35. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
Sun J; Liu L; Zou H; Yu W
Yonsei Med J; 2019 Oct; 60(10):905-913. PubMed ID: 31538425
[TBL] [Abstract][Full Text] [Related]
36. MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: current status and future prospects.
Tan YL; Chen WN
World J Gastroenterol; 2014 May; 20(20):5973-86. PubMed ID: 24876720
[TBL] [Abstract][Full Text] [Related]
37. TLR4 Influences Hepatitis B Virus Related Hepatocellular Carcinoma by Regulating the Wnt/β-Catenin Pathway.
Yin Y; Li F; Li S; Cai J; Shi J; Jiang Y
Cell Physiol Biochem; 2017; 42(2):469-479. PubMed ID: 28578348
[TBL] [Abstract][Full Text] [Related]
38. Dysregulation of β-catenin by hepatitis B virus X protein in HBV-infected human hepatocellular carcinomas.
Chen L; Hu L; Li L; Liu Y; Tu QQ; Chang YX; Yan HX; Wu MC; Wang HY
Front Med China; 2010 Dec; 4(4):399-411. PubMed ID: 21107751
[TBL] [Abstract][Full Text] [Related]
39. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control.
Chang PC; Chi CW; Chau GY; Li FY; Tsai YH; Wu JC; Wu Lee YH
Oncogene; 2006 Mar; 25(14):1991-2003. PubMed ID: 16301996
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B Virus Deregulates the Cell Cycle To Promote Viral Replication and a Premalignant Phenotype.
Xia Y; Cheng X; Li Y; Valdez K; Chen W; Liang TJ
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]